(CRVS) Corvus Pharmaceuticals Renko charts technical analysis
(CRVS) Corvus Pharmaceuticals Renko charts technical analysis Renko analysis of Corvus Pharmaceuticals | Buy/Sell Corvus Pharmaceuticals
Corvus Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Corvus Pharmaceuticals is 1080064
| Date | Closing Price | Open | High | Low | Volume |
| 09 Tue Dec 2025 | 8.67 | 8.64 | 9.20 | 8.49 | 1.719 Mn |
| 08 Mon Dec 2025 | 8.56 | 9.04 | 9.60 | 8.32 | 2.185 Mn |
| 05 Fri Dec 2025 | 8.81 | 8.89 | 9.38 | 8.79 | 1.276 Mn |
| 04 Thu Dec 2025 | 8.81 | 8.44 | 8.90 | 8.40 | 1.225 Mn |
| 03 Wed Dec 2025 | 8.44 | 8.06 | 8.49 | 8.05 | 0.915 Mn |
| 02 Tue Dec 2025 | 8.06 | 8.49 | 8.80 | 8.03 | 1.17 Mn |
| 01 Mon Dec 2025 | 8.51 | 9.17 | 9.17 | 8.31 | 0.888 Mn |
| 28 Fri Nov 2025 | 9.17 | 9.10 | 9.18 | 8.94 | 0.461 Mn |
| 26 Wed Nov 2025 | 9.07 | 8.83 | 9.32 | 8.75 | 0.995 Mn |
| 25 Tue Nov 2025 | 8.87 | 8.56 | 8.92 | 8.49 | 0.726 Mn |
Indicators analysis of Corvus Pharmaceuticals (CRVS)
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Corvus Pharmaceuticals in short term but the sell signal is initial and weak.
Corvus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Corvus Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Corvus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.65 and Corvus Pharmaceuticals (CRVS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Renko charts
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Corvus Pharmaceuticals in short term but the sell signal is initial and weak.
Corvus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Corvus Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Corvus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.65 and Corvus Pharmaceuticals (CRVS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

